since the development of hapten-primed b cells to thymus-dependent carrier requires the presence of carrier-primed helper t cells , dmba treatment seems to affect primarily t cells but not b cells , and the suppression of development of hapten-primed b cells may be a secondary phenomenon induced by the suppressed helper t cell activities .
C0004561
b cells
C1511002
development